Ozempic Injection Schedule: Weekly Dosing & Clinical Timing

Ozempic (semaglutide) is administered as a once-weekly subcutaneous injection, making it one of the most convenient GLP-1 receptor agonist schedules available. The standard dosing protocol begins at 0.25 mg weekly and escalates over 16 weeks, with most patients reaching a maintenance dose of 1.0 mg per week.

Understanding your injection schedule is critical for treatment adherence and response optimization. PlexusDx emphasizes precision-wellness planning: knowing when and how to inject, combined with genetic insights into your peptide pathways, can help you and your provider make more informed decisions about dose timing and potential adjustments.

Standard Weekly Injection Protocol and Dose Escalation

Ozempic follows a predictable four-week dose escalation schedule. Weeks 1–4: 0.25 mg weekly; Weeks 5–8: 0.5 mg weekly; Weeks 9–12: 0.75 mg weekly; Weeks 13–16 and beyond: 1.0 mg weekly. This gradual increase helps your body adjust and reduces gastrointestinal side effects.

Some patients may escalate to the 2.0 mg dose for enhanced glycemic control, though this is typically reserved for those with established tolerability. Your provider determines escalation timing based on your clinical response, tolerability, and metabolic goals.

Injection Timing, Frequency, and Maintenance Considerations

The once-weekly dosing schedule offers flexibility in timing. You can inject on the same day each week, though the injection can be taken any time during a 24-hour window around your chosen day without loss of efficacy. This flexibility supports real-world adherence and reduces missed doses.

Genetic and Biomarker Factors Influencing Dose Tolerance

Genetic variation in the GLP1R gene (rs6923761) and GIPR gene (rs1800437) may influence how your body responds to semaglutide dosing and tolerates the escalation schedule. These predispositions can affect the timeline and dose at which you experience optimal response.

Carriers of certain FTO variants (rs9939609) may show different metabolic responses to GLP-1 therapy. Understanding your genetic profile can help your provider anticipate dose timing adjustments and manage side effects proactively, supporting a more personalized escalation strategy.

When to Pause, Skip, or Adjust Your Injection Schedule

If you experience significant gastrointestinal side effects during escalation—nausea, vomiting, or constipation—your provider may recommend extending the time at your current dose before escalating. Delaying escalation by 1–2 weeks is a standard adjustment that does not reduce treatment efficacy.

Missed doses should be taken as soon as you remember, provided it is at least two days before your next scheduled injection. If a dose is missed and your next injection is within 48 hours, skip the missed dose and resume your regular schedule. Your provider should guide any adjustments to your injection timeline.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test analyzes predispositions in key peptide signaling pathways—GLP1R, GIPR, FTO, and MC4R variants—that may help provide context for how your body responds to once-weekly semaglutide dosing. These genetic insights are not deterministic but can support a more informed conversation with your provider about your likely tolerability and response window.

The genetic test reveals predispositions in peptide metabolism and receptor sensitivity, not exact medication response. A patient with specific GLP1R or GIPR variants may show earlier onset of satiety or different gastrointestinal tolerance during dose escalation, helping providers anticipate individual needs and adjust timing accordingly.

Combining your genetic predispositions with clinical biomarkers—fasting glucose, HbA1c trends, and tolerability observations—creates a more complete picture of your personalized treatment plan. This data can support a detailed conversation with your healthcare provider about whether standard once-weekly escalation, extended dose intervals, or alternative formulations may work best for your unique biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

• Injection Ozempic
• Tirzepatide Dosing Schedule Plexusdx
• Injection Sites For Ozempic
• Ozempic Injection Sites